Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
ECONOMIC EVALUATIONS OF CLINICAL PHARMACY SERVICES - 1988-1995
Autore:
SCHUMOCK GT; MEEK PD; PLOETZ PA; VERMEULEN LC; ALLDREDGE B; AMSDEN G; ANDERSON D; BEDNARCZYK E; GOODWIN SD; JABER L; KNOPPERT D; MUELLER B; OTTO M; POIRIER T; RHO J; SCHEIFE R; SMYTHE M; THOMAS W; THOMPSON D; UDEN D; VASQUEZ E;
Indirizzi:
AMER COLL CLIN PHARM,3101 BROADWAY,SUITE 380 KANSAS CITY MO 64111 WAUSAU HOSP,DEPT PHARM WAUSAU WI 00000 UNIV WISCONSIN HOSP & CLIN,CTR DRUG POLICY & CLIN ECON MADISON NJ 00000 UNIV WISCONSIN HOSP & CLIN,DEPT PHARM MADISON NJ 00000
Titolo Testata:
Pharmacotherapy
fascicolo: 6, volume: 16, anno: 1996,
pagine: 1188 - 1208
SICI:
0277-0008(1996)16:6<1188:EEOCPS>2.0.ZU;2-#
Fonte:
ISI
Lingua:
ENG
Soggetto:
INTENSIVE-CARE UNIT; SIGNIFICANT COST SAVINGS; DRUG-MONITORING PROGRAM; INTERVENTION PROGRAM; PATIENT-CARE; PHARMACOKINETIC SERVICE; INTRAVENOUS RANITIDINE; PHARMACEUTICAL CARE; CONTROLLED TRIAL; BENEFIT-ANALYSIS;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
129
Recensione:
Indirizzi per estratti:
Citazione:
G.T. Schumock et al., "ECONOMIC EVALUATIONS OF CLINICAL PHARMACY SERVICES - 1988-1995", Pharmacotherapy, 16(6), 1996, pp. 1188-1208

Abstract

The objectives of this effort were to summarize and critique originaleconomic assessments of clinical pharmacy services published from 1988-1995, and to make recommendations for future work in this area. A literature search was conducted to identify articles that were then blinded and randomly assigned to reviewers to confirm inclusion, abstract information, and assess the quality of study design. The 104 articles fell into four main categories based on type of service described: disease state management (4%), general pharmacotherapeutic monitoring (36%), pharmacokinetic monitoring services (13%), and targeted drug programs (47%), Articles were categorized by type of evaluation; 35% were considered outcome analyses, 32% outcome descriptions, and 18% full economic analyses. A majority (89%) of the studies reviewed described positive financial benefits from the clinical services evaluated; however, many (68%) did not include the input costs of providing the clinicalservice as part of the evaluation. Studies that were well conducted were most likely to demonstrate positive results. Commonly, results were expressed as net savings or costs avoided for a given time period orper patient. Seven studies expressed results as a benefit:cost ratio (these ranged from 1.08:1 to 75.84:1, mean 16.70:1). Overall this bodyof literature contains a wealth of information pertinent to the valueof the clinical practice of pharmacy. Future economic evaluations of clinical pharmacy services should incorporate sound study design and evaluate practice in alternative settings.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/09/20 alle ore 11:26:56